By Matthew Pillar, Editor, Bioprocess Online
Frequent guest and friend of the Business of Biotech podcast, Allan Shaw, likes to say, “In God we trust. All others must bring data.” The quote, attributed to quality management maven W.E. Deming, applies at every turn of the biopharma business. Investors, regulators, drug hunters, and potential acquirers all live by it. So do the best biopharma leaders. Discovery data rally a molecule into a biopharma business. Development data guide its metered, early growth. Clinical data drive acceleration through regulatory engagement and, eventually, with hope born of data, on to commercialization.